Ibritumomab Tiuxetan and Sinemet 10-100
Determining the interaction of Ibritumomab Tiuxetan and Sinemet 10-100 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Sinemet 100/10
- Ibritumomab Tiuxetan-Sinemet 100/25
- Ibritumomab Tiuxetan-Sinemet 25-100
- Ibritumomab Tiuxetan-Sinemet 25-250
- Ibritumomab Tiuxetan-Sinemet 250/25
- Ibritumomab Tiuxetan-Sinemet CR
- Sinemet 10-100-Ibrutinib
- Sinemet 10-100-Ibrutinib Capsules
- Sinemet 10-100-Ibrutinib Tablets
- Sinemet 10-100-Ibu
- Sinemet 10-100-IBU Tablets
- Sinemet 10-100-Ibu-2